Loading…

Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice

Colitis is an inflammatory condition of the bowels associated with abdominal pain, diarrhea, fatigue, and fever. Its etiology is multifactorial but related to the overproduction of inflammatory and oxidative mediators. There is currently no cure for this disease, and drugs used to manage it often ha...

Full description

Saved in:
Bibliographic Details
Published in:EXCLI journal 2021-01, Vol.20, p.1106-1117
Main Authors: LeBaron, Tyler W, Asgharzadeh, Fereshteh, Khazei, Majid, Kura, Branislav, Tarnava, Alex, Slezak, Jan
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1117
container_issue
container_start_page 1106
container_title EXCLI journal
container_volume 20
creator LeBaron, Tyler W
Asgharzadeh, Fereshteh
Khazei, Majid
Kura, Branislav
Tarnava, Alex
Slezak, Jan
description Colitis is an inflammatory condition of the bowels associated with abdominal pain, diarrhea, fatigue, and fever. Its etiology is multifactorial but related to the overproduction of inflammatory and oxidative mediators. There is currently no cure for this disease, and drugs used to manage it often have deleterious side effects. H 2 is recognized as having anti-inflammatory and antioxidant effects, which may qualify it as a novel therapeutic for colitis. We induced an acute model of colitis in mice by administering dextran sulfate sodium (DSS) in drinking water for seven days. Mice were divided into five groups (n=6); normal, colitis, H 2 -treated colitis, sulfasalazine-treated colitis, and H 2 plus sulfasalazine-treated colitis. From days three to ten, mice were given H 2 , sulfasalazine, or both. H 2 was administered via dissolving a hydrogen-generating tablet in water to make hydrogen-rich water (HRW), which was ingested ad libitum and via oral gavage (200 μL). The Disease Activity Index (DAI), histological changes, and markers of inflammation and oxidative stress were assessed. HRW and sulfasalazine significantly improved bodyweight, DAI, mucosal damage, crypt loss, and spleen weight compared to control. Both treatments significantly decreased inflammation (high-sensitive C-reactive protein) and restored redox balance (total thiol, superoxide dismutase, catalase activity). There was a trend for the combination treatment to be more effective than either HRW or sulfasalazine alone. Furthermore, HRW tended to be as effective as, and often more effective than, sulfasalazine. HRW may serve as a therapeutic for ameliorating DSS-induced colitis in mice.
doi_str_mv 10.17179/excli2021-3762
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8326503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2558092949</sourcerecordid><originalsourceid>FETCH-LOGICAL-p243t-d14cd1857572c286002db2c04355133f2b7b22355081ecec7dbbdc37acfc92583</originalsourceid><addsrcrecordid>eNpVkL1PwzAUxC0EglKYWT2yBOznOE4WJFQ-pSKGwhwc-6UYOXGxE0T564kEA0x3T6f76ekIOeHsjCuuqnP8NN4BA54JVcAOmfGC8wy4LHb_-ANymNIbY7JkUu2TA5GLXIJgM_LyEDya0etIX7c2hjX21CVqQrfRUTce6RBoGn2rk_b6y_VIdaKaDhH10GE_0DZEerVaZa63o0E7Vb0bJoTraecMHpG9VvuEx786J88310-Lu2z5eHu_uFxmG8jFkFmeG8tLqaQCA2XBGNgGDMuFlFyIFhrVAEwHKzkaNMo2jTVCadOaCmQp5uTih7sZmw6tmV6L2teb6Dodt3XQrv6f9O61XoePuhRQSCYmwOkvIIb3EdNQdy4Z9F73GMZUg5zWq6DKK_ENyAByUg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2558092949</pqid></control><display><type>article</type><title>Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice</title><source>PubMed Central (PMC)</source><creator>LeBaron, Tyler W ; Asgharzadeh, Fereshteh ; Khazei, Majid ; Kura, Branislav ; Tarnava, Alex ; Slezak, Jan</creator><creatorcontrib>LeBaron, Tyler W ; Asgharzadeh, Fereshteh ; Khazei, Majid ; Kura, Branislav ; Tarnava, Alex ; Slezak, Jan</creatorcontrib><description>Colitis is an inflammatory condition of the bowels associated with abdominal pain, diarrhea, fatigue, and fever. Its etiology is multifactorial but related to the overproduction of inflammatory and oxidative mediators. There is currently no cure for this disease, and drugs used to manage it often have deleterious side effects. H 2 is recognized as having anti-inflammatory and antioxidant effects, which may qualify it as a novel therapeutic for colitis. We induced an acute model of colitis in mice by administering dextran sulfate sodium (DSS) in drinking water for seven days. Mice were divided into five groups (n=6); normal, colitis, H 2 -treated colitis, sulfasalazine-treated colitis, and H 2 plus sulfasalazine-treated colitis. From days three to ten, mice were given H 2 , sulfasalazine, or both. H 2 was administered via dissolving a hydrogen-generating tablet in water to make hydrogen-rich water (HRW), which was ingested ad libitum and via oral gavage (200 μL). The Disease Activity Index (DAI), histological changes, and markers of inflammation and oxidative stress were assessed. HRW and sulfasalazine significantly improved bodyweight, DAI, mucosal damage, crypt loss, and spleen weight compared to control. Both treatments significantly decreased inflammation (high-sensitive C-reactive protein) and restored redox balance (total thiol, superoxide dismutase, catalase activity). There was a trend for the combination treatment to be more effective than either HRW or sulfasalazine alone. Furthermore, HRW tended to be as effective as, and often more effective than, sulfasalazine. HRW may serve as a therapeutic for ameliorating DSS-induced colitis in mice.</description><identifier>ISSN: 1611-2156</identifier><identifier>EISSN: 1611-2156</identifier><identifier>DOI: 10.17179/excli2021-3762</identifier><identifier>PMID: 34345230</identifier><language>eng</language><publisher>Leibniz Research Centre for Working Environment and Human Factors</publisher><subject>Original</subject><ispartof>EXCLI journal, 2021-01, Vol.20, p.1106-1117</ispartof><rights>Copyright © 2021 LeBaron et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326503/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326503/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>LeBaron, Tyler W</creatorcontrib><creatorcontrib>Asgharzadeh, Fereshteh</creatorcontrib><creatorcontrib>Khazei, Majid</creatorcontrib><creatorcontrib>Kura, Branislav</creatorcontrib><creatorcontrib>Tarnava, Alex</creatorcontrib><creatorcontrib>Slezak, Jan</creatorcontrib><title>Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice</title><title>EXCLI journal</title><description>Colitis is an inflammatory condition of the bowels associated with abdominal pain, diarrhea, fatigue, and fever. Its etiology is multifactorial but related to the overproduction of inflammatory and oxidative mediators. There is currently no cure for this disease, and drugs used to manage it often have deleterious side effects. H 2 is recognized as having anti-inflammatory and antioxidant effects, which may qualify it as a novel therapeutic for colitis. We induced an acute model of colitis in mice by administering dextran sulfate sodium (DSS) in drinking water for seven days. Mice were divided into five groups (n=6); normal, colitis, H 2 -treated colitis, sulfasalazine-treated colitis, and H 2 plus sulfasalazine-treated colitis. From days three to ten, mice were given H 2 , sulfasalazine, or both. H 2 was administered via dissolving a hydrogen-generating tablet in water to make hydrogen-rich water (HRW), which was ingested ad libitum and via oral gavage (200 μL). The Disease Activity Index (DAI), histological changes, and markers of inflammation and oxidative stress were assessed. HRW and sulfasalazine significantly improved bodyweight, DAI, mucosal damage, crypt loss, and spleen weight compared to control. Both treatments significantly decreased inflammation (high-sensitive C-reactive protein) and restored redox balance (total thiol, superoxide dismutase, catalase activity). There was a trend for the combination treatment to be more effective than either HRW or sulfasalazine alone. Furthermore, HRW tended to be as effective as, and often more effective than, sulfasalazine. HRW may serve as a therapeutic for ameliorating DSS-induced colitis in mice.</description><subject>Original</subject><issn>1611-2156</issn><issn>1611-2156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkL1PwzAUxC0EglKYWT2yBOznOE4WJFQ-pSKGwhwc-6UYOXGxE0T564kEA0x3T6f76ekIOeHsjCuuqnP8NN4BA54JVcAOmfGC8wy4LHb_-ANymNIbY7JkUu2TA5GLXIJgM_LyEDya0etIX7c2hjX21CVqQrfRUTce6RBoGn2rk_b6y_VIdaKaDhH10GE_0DZEerVaZa63o0E7Vb0bJoTraecMHpG9VvuEx786J88310-Lu2z5eHu_uFxmG8jFkFmeG8tLqaQCA2XBGNgGDMuFlFyIFhrVAEwHKzkaNMo2jTVCadOaCmQp5uTih7sZmw6tmV6L2teb6Dodt3XQrv6f9O61XoePuhRQSCYmwOkvIIb3EdNQdy4Z9F73GMZUg5zWq6DKK_ENyAByUg</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>LeBaron, Tyler W</creator><creator>Asgharzadeh, Fereshteh</creator><creator>Khazei, Majid</creator><creator>Kura, Branislav</creator><creator>Tarnava, Alex</creator><creator>Slezak, Jan</creator><general>Leibniz Research Centre for Working Environment and Human Factors</general><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210101</creationdate><title>Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice</title><author>LeBaron, Tyler W ; Asgharzadeh, Fereshteh ; Khazei, Majid ; Kura, Branislav ; Tarnava, Alex ; Slezak, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p243t-d14cd1857572c286002db2c04355133f2b7b22355081ecec7dbbdc37acfc92583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LeBaron, Tyler W</creatorcontrib><creatorcontrib>Asgharzadeh, Fereshteh</creatorcontrib><creatorcontrib>Khazei, Majid</creatorcontrib><creatorcontrib>Kura, Branislav</creatorcontrib><creatorcontrib>Tarnava, Alex</creatorcontrib><creatorcontrib>Slezak, Jan</creatorcontrib><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>EXCLI journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LeBaron, Tyler W</au><au>Asgharzadeh, Fereshteh</au><au>Khazei, Majid</au><au>Kura, Branislav</au><au>Tarnava, Alex</au><au>Slezak, Jan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice</atitle><jtitle>EXCLI journal</jtitle><date>2021-01-01</date><risdate>2021</risdate><volume>20</volume><spage>1106</spage><epage>1117</epage><pages>1106-1117</pages><issn>1611-2156</issn><eissn>1611-2156</eissn><abstract>Colitis is an inflammatory condition of the bowels associated with abdominal pain, diarrhea, fatigue, and fever. Its etiology is multifactorial but related to the overproduction of inflammatory and oxidative mediators. There is currently no cure for this disease, and drugs used to manage it often have deleterious side effects. H 2 is recognized as having anti-inflammatory and antioxidant effects, which may qualify it as a novel therapeutic for colitis. We induced an acute model of colitis in mice by administering dextran sulfate sodium (DSS) in drinking water for seven days. Mice were divided into five groups (n=6); normal, colitis, H 2 -treated colitis, sulfasalazine-treated colitis, and H 2 plus sulfasalazine-treated colitis. From days three to ten, mice were given H 2 , sulfasalazine, or both. H 2 was administered via dissolving a hydrogen-generating tablet in water to make hydrogen-rich water (HRW), which was ingested ad libitum and via oral gavage (200 μL). The Disease Activity Index (DAI), histological changes, and markers of inflammation and oxidative stress were assessed. HRW and sulfasalazine significantly improved bodyweight, DAI, mucosal damage, crypt loss, and spleen weight compared to control. Both treatments significantly decreased inflammation (high-sensitive C-reactive protein) and restored redox balance (total thiol, superoxide dismutase, catalase activity). There was a trend for the combination treatment to be more effective than either HRW or sulfasalazine alone. Furthermore, HRW tended to be as effective as, and often more effective than, sulfasalazine. HRW may serve as a therapeutic for ameliorating DSS-induced colitis in mice.</abstract><pub>Leibniz Research Centre for Working Environment and Human Factors</pub><pmid>34345230</pmid><doi>10.17179/excli2021-3762</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1611-2156
ispartof EXCLI journal, 2021-01, Vol.20, p.1106-1117
issn 1611-2156
1611-2156
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8326503
source PubMed Central (PMC)
subjects Original
title Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A23%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20hydrogen%20is%20comparable%20to%20sulfasalazine%20as%20a%20treatment%20for%20DSS-induced%20colitis%20in%20mice&rft.jtitle=EXCLI%20journal&rft.au=LeBaron,%20Tyler%20W&rft.date=2021-01-01&rft.volume=20&rft.spage=1106&rft.epage=1117&rft.pages=1106-1117&rft.issn=1611-2156&rft.eissn=1611-2156&rft_id=info:doi/10.17179/excli2021-3762&rft_dat=%3Cproquest_pubme%3E2558092949%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p243t-d14cd1857572c286002db2c04355133f2b7b22355081ecec7dbbdc37acfc92583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2558092949&rft_id=info:pmid/34345230&rfr_iscdi=true